Adiposogenital dystrophy medical therapy: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 5: Line 5:


==Overview==
==Overview==
The genital signs, low  [[Basal metabolic rate|B.M.R.]], and [[obesity]]  in many cases disappear during or after puberty without any treatment due to genital development and with the correction of [[Basal metabolic rate|B.M.R.]]. The genital under-development seen in adiposogenital dystrophy responds to injections of [[pregnancy]] [[urine]] extract follutein (Squibb).
 
==Medical therapy==
==Medical therapy==
The genital under-development seen in adiposogenital dystrophy responds to injections of [[pregnancy]] [[urine]] extract follutein (Squibb)<ref name="pmidhttps://doi.org/10.1210/endo-23-5-637">{{cite journal| author=Schmoldt A, Benthe HF, Haberland G| title=Digitoxin metabolism by rat liver microsomes. | journal=Biochem Pharmacol | year= 1975 | volume= 24 | issue= 17 | pages= 1639-41 | pmid=https://doi.org/10.1210/endo-23-5-637 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10  }} </ref>
 
==References==
{{reflist|2}}
{{reflist|2}}
{{WH}}
{{WH}}

Revision as of 05:05, 18 August 2021